Agilent XCELLigence RTCA Instrumentation Applied in Recent FDA Approval
March 25, 2025
March 25, 2025
SANTA CLARA, California, March 25 -- Agilent Technologies, a company that specializes in life sciences, diagnostics and applied chemical markets, issued the following news release:
* * *
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
Innovative technology supports testing of accuracy and reliability in Autolus Therapeutics' recently approved CAR T therapy AUCATZYL
Agilent Technologies Inc. (NYSE: A) is pleased to a . . .
* * *
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
Innovative technology supports testing of accuracy and reliability in Autolus Therapeutics' recently approved CAR T therapy AUCATZYL
Agilent Technologies Inc. (NYSE: A) is pleased to a . . .